Chang H, Lee Y, Javed S, Haque M, Chang Y, Lin Y, et al. rAAV-CRISPRa therapy corrects Rai1 haploinsufficiency and rescues selective disease features in Smith-Magenis syndrome mice. J Biol Chem. 2023;299:102728 pubmed publisher

Yang H, Liu B, Liu D, Yang Z, Zhang S, Xu P, et al. Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer. Cancers (Basel). 2022;14: pubmed publisher

Rothenburger T, Thomas D, Schreiber Y, Wratil P, Pflantz T, Knecht K, et al. Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells. J Exp Clin Cancer Res. 2021;40:317 pubmed publisher

Chang Y, Tam H, Lu M, Huang H. Gemcitabine-induced Gli-dependent activation of hedgehog pathway resists to the treatment of urothelial carcinoma cells. PLoS ONE. 2021;16:e0254011 pubmed publisher